SynthesisBMJ open2022

Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials.

Ariel Izcovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.